Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2018-04-29 Interim / Quarterly Rep…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Form 10Q for QTR ended March 31, 2018 33 pages 681.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is described as a 'Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934' for the quarterly period ended March 31, 2018. It contains detailed unaudited condensed consolidated financial statements including balance sheets, income statements, cash flow statements, and notes to the financial statements. It also includes management's discussion and analysis, risk factors, legal proceedings, and other information typical of a quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual quarterly report, not an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2018
2018-04-29 English
Appendix 3B 8 pages 362.8KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It contains detailed information about securities issued or repurchased, including number of securities, class, issue price, purpose of issue, and references to share repurchase programs. The document also references ASX rules and compliance, indicating it is a formal announcement related to capital changes. There is no indication of financial statements, management discussion, or earnings data. The content aligns with announcements about share issues or capital structure changes rather than a full financial report or earnings release. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length (15,000 characters) and detailed content confirm it is not a brief announcement or a report publication notice, but a substantive filing about capital changes.
2018-04-29 English
ResMed Announces Results for the Third Quarter of FY 2018 8 pages 535.3KB
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of ResMed Inc.'s financial results for the third quarter of fiscal year 2018, including comprehensive financial data such as revenue, net income, earnings per share, operating cash flow, and detailed segment analysis. It includes condensed consolidated statements of income, balance sheets, and cash flows, all unaudited but substantive financial statements. The document also discusses impacts of U.S. tax reform, tax audits, debt refinancing, share repurchase, and dividend declarations. The presence of detailed financial statements and analysis for a fiscal quarter clearly indicates this is a quarterly financial report. The document is lengthy (15,000 characters) and contains actual financial data, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2018
2018-04-26 English
Dividend/Distribution - RMD 4 pages 33.5KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about a dividend payment, including the dividend amount, ex-date, record date, payment date, currency, withholding tax rate, and other dividend-related details. It does not contain financial statements or management discussion but is clearly an announcement of dividend payment details to shareholders. This matches the definition of 'Notice of Dividend Amount' (DIV). The document length is about 4982 characters, which is sufficient for a full dividend notice rather than a brief mention or a report publication announcement. Therefore, the correct classification is DIV with high confidence.
2018-04-26 English
Form 8K 292 pages 1.9MB
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 17, 2018, by ResMed Inc. It details the entry into material definitive agreements, specifically an Amended and Restated Credit Agreement and a Syndicated Facility Agreement, which are revolving and term credit facilities respectively. The document includes detailed descriptions of the credit agreements, their terms, covenants, interest rates, and guarantors. The content focuses on financing activities and credit facilities, which are typical of capital or financing updates. There is no indication that this is an annual or quarterly report, audit report, earnings release, or other types of filings. The document is substantive and lengthy (15,000 characters), containing the full text of the credit agreements rather than just an announcement. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-04-19 English
ResMed to Announce Third Quarter Fiscal Year 2018 Results 1
Earnings Release Classification · 95% confidence The document is a short announcement stating that ResMed will report its third quarter fiscal year 2018 results on a future date, including details about the webcast and replay. It does not contain actual financial data or detailed results, but rather informs investors about the upcoming earnings release and webcast. The document length is only 2053 characters, which is short and consistent with an announcement rather than a full report or transcript. Therefore, this fits the category of an Earnings Release (ER) announcement, specifically the initial announcement of quarterly financial results and webcast details. Q3 2018
2018-04-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.